Buy-rated reports

588 tickers rated Buy
Ranks this page's recent reports by score.
Maplebear Inc.
CART·Consumer Discretionary
A ★★★★Buy
Current$50.17
Target$60.00
Return+19.6%
Aug 9, 2026

Instacart pairs a high-growth, high-margin advertising and enterprise software business with a dominant grocery delivery marketplace, generating exceptional free cash flow and executing aggressive buybacks, though investors must monitor gross margin compression from expanding off-platform publisher payments.

Score
86
Republic Services, Inc.
RSG·Industrials
A ★★★★Buy
Current$214.56
Target$232.96
Return+8.6%
Aug 9, 2026

Republic Services leverages an irreplaceable, highly regulated landfill monopoly to exact immense pricing power, funding massive shareholder returns while successfully transforming into a high-margin environmental solutions provider, despite looming regulatory noise around PFAS.

Score
93
Atlassian Corporation
TEAM·Technology
A ★★★★Buy
Current$149.07
Target$189.70
Return+27.3%
Aug 9, 2026

Atlassian is successfully transitioning to an AI-powered cloud model with robust enterprise demand, though investors must navigate near-term headline growth deceleration caused by deliberate Data Center deprecation.

Score
92
Onto Innovation Inc.
ONTO·Technology
A ★★★★Buy
Current$308.30
Target$434.34
Return+40.9%
Aug 9, 2026

Onto Innovation is the highly profitable, structurally dominant tollbooth of the AI advanced packaging revolution, poised to ride the transition to HBM4 and hybrid metrology, though investors must stomach a premium valuation and remain vigilant regarding hyperscaler capital expenditure cycles.

Score
87
Ralph Lauren Corporation
RL·Consumer Discretionary
A ★★★★Buy
Current$395.83
Target$429.58
Return+8.5%
Aug 9, 2026

Ralph Lauren is flawlessly executing a brand elevation strategy with expanding luxury-tier margins and explosive Asian growth, though its elevated multiple leaves little room for macroeconomic missteps.

Score
88
Eli Lilly and Company
LLY·Healthcare
A ★★★★Buy
Current$1,191.94
Target$1,379.02
Return+15.7%
Aug 9, 2026

Eli Lilly is the undisputed clinical kingmaker of the global obesity and diabetes megatrend, leveraging elite pricing power and a generational pipeline to justify its premium valuation, though investors must closely monitor intense supply chain bottlenecks.

Score
85
Albemarle Corporation
ALB·Materials
A ★★★★Buy
Current$131.11
Target$183.31
Return+39.8%
Aug 9, 2026

Albemarle's monopoly-like grip on the world's lowest-cost lithium assets and its newly fortress-like balance sheet make it a deeply undervalued vehicle to ride the structural energy transition, though investors must stomach extreme cyclical volatility and lingering Chilean geopolitical overhangs.

Score
92
Manulife Financial Corporation
MFC·Financials
A ★★★★Buy
Current$44.55
Target$48.50
Return+8.9%
Aug 8, 2026

Manulife Financial Corporation is a massively capitalized financial fortress offering elite dividend yields and a powerful Asian growth engine, making it a compelling high-quality compounder despite inherent macroeconomic sensitivities.

Score
87
Uber Technologies, Inc.
UBER·Technology
A ★★★★Buy
Current$74.95
Target$106.92
Return+42.7%
Aug 8, 2026

Uber is a dominant, cash-gushing global aggregator successfully leveraging a unified mobility-delivery platform to scale high-margin advertising, though investors must continuously monitor the existential risks of European labor reclassification and the long-term threat of vertically integrated autonomous networks.

Score
91
AppLovin Corporation
APP·Technology
A ★★★★Buy
Current$335.67
Target$592.76
Return+76.6%
Aug 8, 2026

AppLovin is a hyper-scalable, highly profitable tollbooth for digital advertising powered by its elite AXON 2.0 AI engine, trading at a deceptively cheap forward valuation, though investors must remain vigilant regarding unresolved SEC data probes and ongoing short-seller litigation noise.

Score
91
Expedia Group, Inc.
EXPE·Consumer Discretionary
A ★★★★Buy
Current$310.68
Target$360.00
Return+15.9%
Aug 8, 2026

Expedia is rapidly transforming from a mature consumer travel portal into the foundational, high-margin B2B infrastructure of the global hospitality ecosystem, trading at an irrationally cheap 15x forward multiple while aggressively shrinking its share count, though investors must remain vigilant regarding cyclical macro travel pullbacks and algorithmic dependence on Google.

Score
93
Shopify Inc.
SHOP·Technology
A ★★★★Buy
Current$147.44
Target$165.60
Return+12.3%
Aug 8, 2026

Shopify is cementing itself as the undisputed backbone of global commerce through accelerating top-line growth, dominant B2B expansion, and pioneering the Universal Commerce Protocol (UCP), though its steep valuation multiple demands flawless execution.

Score
89
IonQ, Inc.
IONQ·Technology
A ★★★★Buy
Current$40.29
Target$53.58
Return+33.0%
Aug 8, 2026

IonQ leverages world-record 99.99% gate fidelity and the $1.8B SkyWater foundry acquisition to dominate the quantum sector, though investors must monitor heavy cash burn amid rapid scaling.

Score
87
Occidental Petroleum Corporation
OXY·Energy
A ★★★★Buy
Current$56.27
Target$78.00
Return+38.6%
Aug 8, 2026

Occidental has successfully transformed into a hyper-efficient, low-cost Permian cash machine trading at a heavily discounted valuation, though investors must remain patient as management channels billions in free cash flow toward debt destruction and preferred equity redemption rather than immediate share buybacks.

Score
94
CorVel Corporation
CRVL·Healthcare
A ★★★★Buy
Current$62.45
Target$71.00
Return+13.7%
Aug 8, 2026

CorVel is a highly profitable, debt-free quality compounder transitioning to generative AI-driven claims management, leveraging its massive CERIS payment integrity division to offset the structural industry-wide declines in workers' compensation claim volumes.

Score
85
Stride, Inc.
LRN·Consumer Discretionary
A ★★★★Buy
Current$82.58
Target$109.00
Return+32.0%
Aug 7, 2026

Stride is executing a highly lucrative structural pivot into adult career learning supported by massive free cash flow and a fortress balance sheet, offering an exceptionally cheap valuation, though investors must vigilantly monitor the legacy K-12 business as pandemic-era federal subsidies evaporate and regulatory scrutiny intensifies.

Score
88
EOG Resources, Inc.
EOG·Energy
A ★★★★Buy
Current$134.23
Target$158.40
Return+18.0%
Aug 8, 2026

EOG Resources is the undisputed gold standard of U.S. shale operators, executing a masterclass in capital discipline and cash returns through its elite 'premium drilling' cost advantages, making it a must-own compounder in any structurally tight energy market.

Score
89
Upstart Holdings, Inc.
UPST·Financials
A ★★★★Buy
Current$29.71
Target$46.60
Return+56.8%
Aug 7, 2026

Upstart is an underpriced AI powerhouse capturing massive share in consumer lending with 2.74x the accuracy of traditional models and re-accelerating GAAP profitability, though investors must remain vigilant regarding the inherent cyclicality of macroeconomic credit shocks.

Score
87
Public Service Enterprise Group Incorporated
PEG·Utilities
A ★★★★Buy
Current$76.68
Target$83.54
Return+8.9%
Aug 8, 2026

PSEG offers the ultimate dual-engine utility infrastructure play, combining a relentlessly compounding, low-risk New Jersey distribution grid with the explosive, unpriced upside of a carbon-free nuclear fleet entering a historic era of PJM capacity scarcity, though investors must vigilantly monitor emerging FERC regulatory hurdles regarding hyperscaler co-location.

Score
89
Coca-Cola Europacific Partners PLC
CCEP·Consumer Staples
A ★★★★Buy
Current$108.25
Target$125.00
Return+15.5%
Aug 7, 2026

Coca-Cola Europacific Partners operates an unassailable, cash-printing regional bottling monopoly that utilizes its mature European pricing power to aggressively fund shareholder returns and scale its lucrative Southeast Asian growth engine, though investors must remain vigilant regarding tightening EU packaging regulations.

Score
85
Jazz Pharmaceuticals plc
JAZZ·Healthcare
A ★★★★Buy
Current$256.65
Target$310.00
Return+20.8%
Aug 7, 2026

Jazz is successfully utilizing the immense cash flows from its resilient neuroscience monopoly to aggressively fund an explosive, deeply undervalued oncology pipeline, though investors must remain highly vigilant regarding competitive encroachment from once-nightly narcolepsy alternatives.

Score
89
BP p.l.c.
BP·Energy
A ★★★★Buy
Current$44.25
Target$53.21
Return+20.2%
Aug 7, 2026

BP is a formidable cash-generation engine trading at an extreme, unwarranted discount to US supermajors, poised for a major rerating as its ruthless new CEO drives operational efficiency, though investors must monitor the volatility of global refining margins and legacy environmental payouts.

Score
87
Energy Transfer LP
ET·Energy
A ★★★★Buy
Current$20.59
Target$25.00
Return+21.4%
Aug 7, 2026

Energy Transfer leverages its unparalleled 140,000-mile infrastructure footprint to capture the surging natural gas demand from AI data centers, offering a compelling 6.69% yield and cheap valuation, though investors must monitor its heavy debt load and acquisition-driven dilution.

Score
92
Revvity, Inc.
RVTY·Healthcare
A ★★★★Buy
Current$113.69
Target$128.26
Return+12.8%
Aug 7, 2026

Revvity is a highly profitable, cash-generative tollbooth for the AI-driven life sciences revolution, trading at a compelling discount to peers as it sheds legacy assets, though investors must monitor transient lumpiness in enterprise software renewals.

Score
92